Search for: "Perrigo Company"
Results 61 - 80
of 87
Sort by Relevance
|
Sort by Date
27 May 2010, 7:09 am
Perrigo supplies generic equivalent drugs to many of the nation's biggest pharmacy chains, including Walgreens and CVS. [read post]
26 Apr 2010, 7:22 pm
Soltis – In an advertising challenge brought by the Perrigo Company (“Perrigo”), the National Advertising Division (“NAD”) of the Better Business Bureau recommended that Pharmavite, LLC (Pharmavite) refrain from making several claims for its Nature Made® Prenatal + DHA Liquid Softgel Vitamins until the company completes competent and reliable testing that establishes the bioavailability of the folic acid in the product. [read post]
21 Apr 2010, 10:08 am
The case involved Perrigo Company, a producer of dietary supplements for the private label market, and Rexall Sundown, Inc. [read post]
17 Feb 2010, 5:10 am
(IP Whiteboard) EU: European Commission probes for evidence of foul play among pharmaceutical companies (IP Whiteboard) EU / UK: Of conflict and cooperation: when national courts and the EPO differ: Eli Lilly and Company v Human Genome Sciences (PatLit) India: Drug makers decry Indian patent law (GenericsWeb) India: India-EU gets flak in India (GenericsWeb) India: Delhi High Court: Rejection of application based on pre-grant representation may be appealed to IPAB: UCB Farchim SA v… [read post]
16 Dec 2009, 3:39 am
Perrigo Co. et al. [read post]
2 Dec 2009, 4:31 am
Because other countries just decide to pay less – Pfizer’s patent battle against UniLab (Patent Baristas) Moxifloxacin – Venezuela annuls two of Bayer’s patents relating to Moxifloxacin (IP tango) (IP tango) Plavix (Clopidogrel) – India: Indian company, Cadila, bears the brunt of section 3(d) (Spicy IP) Sanctura (Trospium) – US: Allergan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Taxotere (Docetaxel)… [read post]
1 Dec 2009, 9:45 am
Perrigo Company, Perrigo Israel Pharmaceuticals Ltd. [read post]
1 Dec 2009, 8:03 am
" Here is how Perrigo describes its business model: The Perrigo Company manufactures products that compare to national brand products such as Tylenol®, Advil® or ONE-A-DAY®. [read post]
21 Oct 2009, 6:13 am
(Afro-IP) 200,000 die annually because of fake malaria medicine – Smithsonian article ‘The Fatal Consequences of Counterfeit Drugs’ (Innovationpartners) ‘Translational medicine’ (IPKat) Brazil: Brazilian Ministry of Health calls for partnerships between public laboratories and private companies (IP tango) Brazil: Rio 2016 – who will pay and how? [read post]
21 Oct 2009, 5:13 am
(Afro-IP) 200,000 die annually because of fake malaria medicine - Smithsonian article 'The Fatal Consequences of Counterfeit Drugs' (Innovationpartners) 'Translational medicine' (IPKat) Brazil: Brazilian Ministry of Health calls for partnerships between public laboratories and private companies (IP tango) Brazil: Rio 2016 - who will pay and how? [read post]
21 Oct 2009, 5:13 am
(Afro-IP) 200,000 die annually because of fake malaria medicine - Smithsonian article 'The Fatal Consequences of Counterfeit Drugs' (Innovationpartners) 'Translational medicine' (IPKat) Brazil: Brazilian Ministry of Health calls for partnerships between public laboratories and private companies (IP tango) Brazil: Rio 2016 - who will pay and how? [read post]
17 Apr 2009, 12:00 am
Ltd. sues 11 generics companies over Levaquin patents (Law 360) Lexapro (Escitalopram) – Netherlands District court invalidates Lundbeck’s patent EP ‘066 (IPKat) Lexapro (Escitalopram) - Baldwin’s rules explained (The SPC Blog) Lexapro (Escitalopram) – federal district Judge agrees to determine whether Forest Laboratories destroyed key documents (Law 360) Pegasys (PEG interferon alfa 2a) – Roche wins post grant opposition against… [read post]
3 Apr 2009, 2:36 am
The PIMCO mutual fund lawsuit joins recent lawsuits filed against Perrigo Company (about which refer here) and NextWave Wireless (refer here), as examples of cases in which auction rate securities buyers are targeted by their own investors for their exposure to the instruments. [read post]
1 Apr 2009, 2:07 am
The most recent of these cases, involving Perrigo Company, is discussed here. [read post]
31 Mar 2009, 4:03 am
Shareholders of Perrigo Company recently filed suit in the United States District Court for the Southern District of New York against Perrigo, a pharmaceutical manufacturer and distributor and seven of its directors and officers, alleging violations of Section 10(b) and Rule 10b-5 of the 1934 Securities Exchange Act. [read post]
12 Mar 2009, 2:15 am
Nor is Perrigo the first company to be exposed to securities litigation as a consequence of Lehman’s bankruptcy. [read post]
19 Sep 2008, 6:00 pm
: (IP finance), United States: An open letter for the General Counsel of the PTO on your San Diego presentation next week: (Hal Wegner), United States: Cocoa genome: breaking intellectual property barriers: (Thomson Reuters Scientific), Vietnam: Patentability of second medical use claims in Vietnam is again questionable: (Trung Truc JSC) Pharma & Biotech - Products Allegra (Fexofenadine) - Canada: Motion for summary judgment of noninfringement dismissed in patent infringement… [read post]
12 Sep 2008, 2:33 pm
: (IP finance), MARQUES international advertising portal goes live: (Class 46) Global - Patents Using patent landscaping analytics to improve the quality of M & A decisions: a review of Cox Enterprises’ $300M purchase of Adify: (IP Asset Maximiser Blog), Universities reap royalty rewards; investors ignore IP at their peril: (IAM), Top IP-owning nations claim faster patent processing; near harmonisation deal: (Intellectual Property Watch), Bosch, Xerox and Dupont sign up… [read post]
2 May 2008, 7:00 am
, India: Mint story on patent loophole in India regarding the importation of generics: (Spicy IP), India: WHO lambasts Indian drug regulatory system: (Spicy IP), India: Minister to ensure that reduced excise duty to reflect in drug prices: (Spicy IP), India: SCC journal article ‘Intellectual property rights and the challenges faced by the pharmaceutical industry’: (Spicy IP), Poland: Trade marks for medicines: (Class 46), US: IPO publishes letter in… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
